Goldenseal Ginseng (Hydrastis canadensis)
Goldenseal ginseng (Hydrastis canadensis) contains berberine and hydrastine as primary bioactive alkaloids that demonstrate antimicrobial activity through bacterial cell wall disruption. This herb modulates cytochrome P450 enzymes, particularly CYP2D6 and CYP3A4, potentially affecting drug metabolism.

Origin & History
Goldenseal (Hydrastis canadensis) is a perennial herb native to the eastern woodlands of North America, belonging to the Ranunculaceae family, not actually related to ginseng (Panax species). The active extracts are typically obtained through ethanol or water extraction of dried roots and rhizomes, which contain isoquinoline alkaloids.
Historical & Cultural Context
Goldenseal has been used in Native American traditional medicine for infections and inflammation, though specific duration or systems are not detailed. The plant was historically overharvested for its rhizomes and roots.
Health Benefits
• Antifungal activity demonstrated in vitro against pathogens affecting American ginseng plants (preliminary evidence only) • Potential antimicrobial properties based on traditional use (no human clinical trials available) • May modulate drug metabolism through CYP450 enzyme inhibition (in vitro evidence only) • Historical use for infections and inflammation in Native American medicine (traditional evidence only) • No human clinical trials or RCTs available to substantiate health benefits
How It Works
Berberine and hydrastine alkaloids in goldenseal ginseng disrupt bacterial cell membrane integrity and inhibit DNA gyrase activity. These compounds strongly inhibit cytochrome P450 enzymes CYP2D6 and CYP3A4, slowing hepatic drug metabolism. The antimicrobial effects occur through interference with bacterial protein synthesis at the ribosomal level.
Scientific Research
No human clinical trials, RCTs, or meta-analyses for goldenseal (Hydrastis canadensis) were found in the research. Available studies focus only on in vitro antifungal effects against plant pathogens, and drug interaction potential through CYP3A4 and P-glycoprotein inhibition (PMID: 17495878; PMID: 17611934).
Clinical Summary
Current evidence for goldenseal ginseng consists primarily of in vitro studies demonstrating antifungal activity against plant pathogens. No randomized controlled trials in humans have been completed for this specific combination. Traditional use studies suggest antimicrobial properties, but clinical efficacy remains unproven. Laboratory studies show significant CYP450 enzyme inhibition, indicating potential for drug interactions.
Nutritional Profile
Goldenseal (Hydrastis canadensis) is not consumed as a food source and lacks a conventional nutritional profile of macronutrients. It is valued primarily for its bioactive alkaloid content. Key bioactive compounds: **Berberine** (approximately 0.5–6.0% of dried root/rhizome weight, typically ~2.5–4.5% in quality preparations), **Hydrastine** (β-hydrastine, approximately 1.5–5.0% of dried root, often the most abundant alkaloid), and **Canadine** (tetrahydroberberine, approximately 0.5–1.0%). Minor alkaloids include **berberastine**, **canadaline**, and **palmatine** (trace amounts, typically <0.5%). Other bioactive constituents: **Chlorogenic acid** and related phenolic acids (trace), small amounts of **resin** (~3–4%), **volatile oils** (trace), **lipids** (~3%), and **starch**. Mineral content in dried root includes trace amounts of **iron**, **manganese**, **calcium**, **phosphorus**, and **potassium**, though concentrations are not nutritionally significant at typical supplement doses (500–2000 mg/day). Contains negligible protein, fat, and dietary fiber at supplemental dosages. **Bioavailability notes**: Berberine has notably low oral bioavailability (estimated <5% in humans) due to extensive first-pass metabolism and P-glycoprotein efflux in the gut. Hydrastine is somewhat better absorbed but data are limited. CYP3A4 and CYP2D6 inhibition by goldenseal alkaloids (particularly hydrastine and berberine) can alter bioavailability of co-administered pharmaceuticals. Alkaloid content varies significantly with plant part (rhizome > roots > leaves), growing conditions, harvest time (typically harvested after 3–5 years of growth in autumn), and extraction/processing methods. Standardized extracts are typically standardized to 5% total alkaloids or ~3.5% berberine plus hydrastine combined.
Preparation & Dosage
No clinically studied dosage ranges are available for goldenseal in human trials. In vitro studies used extracts without quantified human-equivalent doses. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
American ginseng, echinacea, astragalus, berberine, Oregon grape
Safety & Interactions
Goldenseal ginseng can significantly increase blood levels of medications metabolized by CYP2D6 and CYP3A4 enzymes, including many antidepressants and blood thinners. Common side effects include gastrointestinal upset, nausea, and potential liver enzyme elevation with prolonged use. Pregnant and breastfeeding women should avoid use due to berberine's potential uterine stimulant effects. Individuals with liver disease or those taking multiple medications should consult healthcare providers before use.